دورية أكاديمية
Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M): A Subgroup Analysis by Prior Type of Premix Insulin
| العنوان: | Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M): A Subgroup Analysis by Prior Type of Premix Insulin |
|---|---|
| المؤلفون: | Aravind, S. R.Aff1, Aff2, Singh, Kiran P., Mogylnytska, Liliia, Zalevskaya, Alsu G., Matyjaszek-Matuszek, Beata, Wernicke-Panten, Karin, Nguyên-Pascal, My-Liên, Pierre, Suzanne, Rotthaeuser, Baerbel, Kramer, Daniel, Mukherjee, BhaswatiAff9, IDs1330002201279z_cor11 |
| المصدر: | Diabetes Therapy: Research, treatment and education of diabetes and related disorders. 13(7):1299-1310 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 18696953 18696961 |
|---|---|
| DOI: | 10.1007/s13300-022-01279-z |